期刊文献+

ICD围术期未停口服抗凝药的临床观察和护理 被引量:1

Clinical observation and nursing of implantable cardioverter-defibrillator patients with oral anticoagulants in the peroperative period
下载PDF
导出
摘要 目的探讨植入型心律转复除颤器(ICD)围术期未停口服抗凝药的临床观察和护理。方法回顾ICD植入术35例患者,其中围术期未停抗凝药15例,总结护理要点和并发症的处理方法。结果 35例行ICD植入术患者均痊愈出院,随访患者无不良反应和并发症。结论术前全面评估患者围术期是否停用或替代抗凝剂,同时做好患者教育及凝血监测工作,术后严密观察术区情况,发现异常及时处理。 Objective To explore the clinical manifestations and nursing of implantable cardioverter-defibrillator(ICD) patients with oral anticoagulants in the peroperative period.Methods The clinical data of 35 ICD patients were reviewed.Among them,15 patients continued the oral anticoagulants.The nursing highlights and the ways to deal with complications have been summarized.Results All patients were discharged from hospital with good recovery.Follow-up showed that there were no adverse reactions and complications.Conclusion Comprehensive assessment should be done to identify whether patients has discontinued oral anticoagulants or other substitutes in the perioperative period before surgery.Meanwhile,health education and coagulation should be properly managed.The progression of disease should be closely observed after surgery in case of emergencies.
出处 《实用临床医药杂志》 CAS 2012年第6期23-25,共3页 Journal of Clinical Medicine in Practice
关键词 ICD 口服抗凝药 围术期 观察 护理 implantable cardioverter-defibrillator oral anticoagulation peroperative Period observation nursing
  • 相关文献

参考文献12

二级参考文献90

  • 1张建军,杨新春,胡大一,商丽华,汪爱虎,陈明.462例永久起搏器置入术并发症的相关因素分析及防治对策[J].中国心脏起搏与心电生理杂志,2004,18(6):456-457. 被引量:64
  • 2冯义柏.心脏起搏器植入技术指南[J].中华心律失常学杂志,1998,2(3):217-224. 被引量:31
  • 3Wiegand UK,LeJeune D,Boguschewski F,et al.Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery:influence of patient morbidity,operation strategy,and perioperative antiplatelet/anticoagulation therapy[J].Chest,2004,126(4):1 177.
  • 4Klinkhardt U,Kirchmaier CM,Westrup D,et al.Ex vivo-in vitro interaction between aspirin,clopidogrel,and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A[J].Clin Pharmacol Ther,2000,67:305.
  • 5Harder S,Klinkhardt U,Alvarez JM.Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy:pharmacokinetic and pharmacodynamic considerations[J].Clin Pharmacokinet,2004,43(14):963.
  • 6Weber AA,Braun M,Hohlfeld T,et al.Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers[J].Br J Clin Pharmacol,2001,52(3):333.
  • 7Jaffer AK,Ahmed M,Brotman DJ,et al.Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy:a standardized bridging therapy protocol[J].J Thromb Thrombolysis,2005,20(1):11.
  • 8Larson BJ,Zumberg MS,Kitchens CS.A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk[J].Chest,2005,127(3):922.
  • 9Goldstein DJ,Losquadro W,Spotnitz HM.Outpatient pacemaker procedures in orally anticoagulated patients[J].PACE,1998,21(9):1 730.
  • 10Al-Khadra AS.Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients[J].PACE,2003,26(1 Pt 2):511.

共引文献321

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部